PHIO·71880W501·US·equity·Healthcare - Biotechnology-13D/G
PHIO (PHIO PHARMACEUTICALS CORP) is held by 13 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($179,649), JANE STREET GROUP, LLC ($145,410), Cetera Investment Advisers ($54,900). Net institutional sentiment: Bullish.
See how PHIO's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer